Our deputy director, Professor Kiat Ruxrungtham, was awarded the Excellent Researcher Award by the Thai Research…
Category: News
An overall picture of the current situation of HIV/AIDS in Asia
Dr. Kiat Ruxungtham, our deputy director, has well provided all of the information in an easy…
Where there is a will, there is a way to achieve UNAIDS 90/90/90 goals by 2020!
More than 500 researchers, scientists and experts have signed the Vancouver Consensus at the end of…
START paper published in 2015
The START study had 2 groups: 1. start HIV treatment as soon as possible, also known…
HIV HCV TB Pipeline Report
As a global community of people living with HIV, our needs from the antiretroviral (ARV) pipeline…
Hot off the press coverage of our clinical trial physicians’ presentations at IAS 2015!
Associate Professor Thanyawee Puthanakit’s talk on “HIV Co-morbidities in children and adolescents” addressed what kind of…
Bangkok MSM HIV/AIDS Report
From: The World Bank AUTHORS Zhang, Lei; Phanuphak, Nittaya; Henderson, Klara; Nonenoy, Siriporn; Srikaew, Sasiwan; Shattock,…
When to start antiretroviral treatment in adults?
The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), USA, has…
Treating HIV Patients Before They Get Sick
A major international clinical trial has provided the strongest evidence yet that people infected with H.I.V.,…
When to start anti-AIDS drugs?
WASHINGTON (AP) — A major international study says HIV patients shouldn't delay in seeking treatment: Starting…
Early Treatment Best for HIV, Study Confirms
People who started taking AIDS drugs soon after they were diagnosed were healthier and had fewer…
Begin HIV treatment immediately says major study, ending long debate
A study in 35 countries that involved 4685 HIV-infected people has ended early because results showed…
i-Base Q&A on the START study results
The START study is a large international HIV study. It looks at the risks and benefit…
Questions and Answers The START HIV Treatment Study
From: National Institutes of Allergy and Infectious Diseases 1. What is the START study? The START (“Strategic…
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-Infected Individuals
A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk…
